Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Dr. William Ziegler and Dr. Alan Martinez of the Reproductive Science Center of NJ Named NJ Top Docs


Reproductive Science Center

Reproductive Science Center

In light of the recent Supreme Court’s decision to overturn Roe v. Wade, we want to reassure patients that this will not affect their care in our office. Our state supports reproductive rights, which includes treatment for infertility.

Dr. William Ziegler and Dr. Alan Martinez of the Reproductive Science Center of New Jersey, have been reviewed and approved based on merit by NJ Top Docs. These NJ Top Docs strive to provide the highest quality medical care in a comfortable compassionate environment and want you to know that no matter the state of the country, they are here for you.

“In light of the recent Supreme Court’s decision to overturn Roe v. Wade, we want to reassure patients that this will not affect their care in our office. Our state supports reproductive rights, which includes treatment for infertility,” say the doctors.

They understand the significance of the Supreme Court’s decision and are here to assist those in need of reproductive services.

From day one, our practice has strived to “provide the highest quality care in a caring and compassionate environment,” says Dr. Ziegler.

“We offer a boutique practice. Each patient has their own coordinator,” Dr. Martinez adds. “This person will hold their hand and help them navigate through the stressful process and ultimately achieve a pregnancy.”

The practice continues to expand its fertility services so patients receive the most advanced medical care. This includes offering donor egg, genetic testing of embryos, and fertility preservation for medical and social reasons.

The practice also supports many organizations within their area including Mary’s Place, American Cancer Association, and many LGBTQ+ support groups.

“When treating the infertile patient, you need to understand the psychological impact this has on their life. We understand this disease can affect their work performance, interaction with others, and marital discord. We address the psychological component as well as the medical issues,” says Dr. Ziegler.

To learn more about the Reproductive Science Center of New Jersey, please visit: https://njtopdocs.com/nj-doctors/rscnj/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Warriors Heart recognized by 2023 Real Leaders Impact Awards in 300 Top Impact Companies Worldwide


Warriors Heart has been recognized by the 2023 Real Leaders Impact Awards, for the fourth year in a row as one of the top 300 purpose-driven organizations making a positive impact worldwide.

We are grateful to be recognized by the 2023 Real Leaders Impact Awards as Number 4 in Healthcare and 102 Overall. Our long-term focus continues to be on people and leadership development, which has been a huge part of achieving this award, year-after-year. – Josh Lannon, Warriors Heart CEO/Founder

Warriors Heart has been recognized by the 2023 Real Leaders Impact Awards for the fourth year in a row as one of the Top 300 Impact Companies in the world. Warriors Heart CEO/Founder Josh Lannon expressed his sincere gratitude, “We are grateful to be recognized as Number 4 in Healthcare and 102 Overall. Our long-term focus continues to be on people and leadership development, which has been a huge part of achieving this award, year-after-year.”

Real Leaders Founder Mark Van Ness explains, “We are excited to welcome new and past company winners to the impact movement, and into the Real Leaders Impact Awards community. This is our fifth annual ranking and the number of award winners has tripled. It’s encouraging to see how this movement is going mainstream with businesses all over the world.”

Warriors Heart officially opened in 2016 as the first and ONLY private and accredited residential treatment and training program in the United States that is exclusively for our frontline protectors (active-duty military, veterans and first responders). This multi-level program includes healing options for warriors struggling with drug and alcohol addiction, PTS (post-traumatic stress), mild TBI (traumatic brain injury) and co-occurring issues.

Since officially opening in 2016, Warriors Heart has grown from 40 to 100 licensed residential treatment beds, 52 sober living beds and offers space in its Intensive Outpatient Program (IOP) for up to 30 clients. Since 2016, it has served 2000+ clients.

A virtual awards ceremony will be held on February 16, 2023 to honor the Real Leaders winners, and will feature several high profile keynote speakers.

2023 Real Leaders Awards – 300 Top Impact Companies in 2023

Media Contact for Warriors Heart:

Liz Kelly, 310-987-7207

ABOUT REAL LEADERS

Real Leaders is a membership community for impact leaders with a global media platform dedicated to driving positive change. It’s on a mission to unite farsighted leaders to transform our shortsighted world. Founded in 2010, Real Leaders recognized early on that businesses bore a responsibility to be as cognizant of their impact on employees, society, and the planet as they are on their bottom line. Real Leaders is a B Corporation, member of the UN Global Compact, and is independently owned.

ABOUT WARRIORS HEART

(Bandera, Texas near San Antonio) is the first and only private and accredited treatment program in the U.S. exclusively for “warriors” (active duty military, veterans, first responders and EMTs/paramedics) faced with the self-medicating struggles of alcohol addiction, prescription and drug addiction, PTSD (post-traumatic stress disorder), mild TBI (Traumatic Brain Injury) and other co-occurring issues in a private, 60-bed facility on a 543-acre ranch. Along with a minimum 42-day peer-to-peer residential treatment program, Warriors Heart offers a full continuum of care. Warriors are given the option of Detox, Day Treatment, Intensive Outpatient Program (IOP), Sober Living (60-day minimum) and Aftercare. Warriors Heart’s work has been featured on the TODAY Show, CBS Health Watch, A&E Intervention, KENS 5 CBS San Antonio, National Defense Radio Show and in TIME, Forbes, The Chicago Tribune, Addiction Pro magazine, Stars and Stripes, and many more. There is a 24-hour Warriors Heart hotline (844-448-2567) answered by warriors. https://warriorsheart.com

Share article on social media or email:

Local Dental Office Downtown Dental Joins the Boys and Girls Clubs in the War Against Illiteracy!


Downtown Dental Los Angeles supports your Boys and Girls Clubs!

Dr. Mungcal, having served his community for many years, was quoted as saying, “This is an outrage! Only someone who doesn’t care about this city and our children would keep this quiet. Something should be done about this!”

During a special leadership event held in Florida, several business owners joined forces and decided to band together to do something about this.

They started by sending over 1,000 books to Boys and Girls Clubs in their communities. The mission of Boys and Girls Clubs is to enable all young people to reach their full potential as productive, caring, responsible citizens, especially those in need. These leaders support the vision of this national network of world-class clubs putting hope and safety within reach of every young person, and putting them on track to graduate from high school with a plan for the future, learning good character and citizenship, and living a healthy lifestyle.

Reading is a cornerstone skill for our youth!

Dr. Mungcal said, “We want to do our part. And we want everyone in this city to know about this program and support it. Boys and Girls Clubs are leading the way in showing us that something can be done about it; something can be done about illiteracy by everyone pitching in.” and further stated “I believe that children and young adults who are shown what’s possible through literature can achieve their dreams. What’s more, receiving the gift of reading really makes them happy and ignites their imagination. I love making giving them this opportunity.”

About the Doctor Mungcal:

Dr. Don Mungcal is a native of the Los Angeles area and loves serving his neighbor’s dental

Share article on social media or email:

Nonprofit Organization to Award Research Funds for the Study of Pulmonary Hypertension


Nonprofit organization Team PHenomenal Hope (Team PH) is proud to announce the fifth year of accepting research proposals for the PHenomenal Impact Fund for Global PH Research. The organization will reward studies of novel concepts in pulmonary hypertension (PH) with a potential to transform the field. Letters of intent (LOI) will be accepted until Tuesday, February 14.

This program provides opportunities for individuals to affect the quality of medical care and improve the lives of patients with PH. The fund itself was created by Team PH; it provides awards of $50,000 to investigators during a 12-month period. The awards are chosen by the organization’s Research Award Steering Committee based on scientific merit, originality, feasibility, and/or clinical applicability to the diagnosis and treatment of people living with PH.

The organization is thrilled to continue advancing progress to better treat and eventually cure PH. Since 2019, the Team PH has received an abundance of proposals from investigators worldwide that targeted clinical application in translational science. Most recently, Dr. Arun Jose of the University of Cincinnati received the 2022 Team PH Research Award for his submission titled, “Circulating gut-derived metabolites as markers of disease severity in PAH.”

This year, proposals must be deemed achievable within the one year time frame and within the noted fiscal allocation. Eligibility extends not only to the United States, but also to countries who have an established Team PHenomenal Hope presence, including Belgium, Brazil, Germany, Mexico, and South Africa. The award winner will be announced in early May.

To learn more about eligibility, the timeline of the application process, and to apply, visit http://www.teamphgrants.org. For any questions please email mailto:research@teamphenomenalhope.org [research@teamphenomenalhope.org __title__ ] or call 877-646-4673 extension 101.

Share article on social media or email:

Job Snob and the American Med Spa Association (AmSpa) Form New Partnership to Create Medical Aesthetic Job Board


“Hiring is such a critical component of the industry’s continued growth and safety, and what Job Snob has created will make finding qualified and safe providers much easier,” says AmSpa founder and CEO, Alex R. Thiersch, JD.

Job Snob has partnered with the American Med Spa Association (AmSpa) to power a job board designed for the medical aesthetic industry. This partnership connects the association’s network of medical aesthetic professionals with experienced industry candidates, allowing medical spas to strengthen their teams with a wide variety of roles, from entry-level and support roles to skilled medical positions, as well as concierge services to help medical spa owners find the right injectors, practice managers and director-level talent.

“We are thrilled to form a partnership with the medical spa industry’s go-to for business, legal and compliance resources,” says Job Snob co-founder, Kipper Doughty. “Job Snob hopes to bring more value to AmSpa members by providing greater access to concierge recruiting and the leading medical aesthetic job board.”

AmSpa Members now have access to special pricing on job postings to the medical aesthetic job board, concierge and white-glove recruitment, and acquisition matchmaking through Job Snob. All AmSpa Members receive 10% off job packages. Click here to visit the job board and learn more.

“We’re so excited for this partnership and for the launch of the new Job Snob job board,” says AmSpa founder and CEO, Alex R. Thiersch, JD. “Hiring is such a critical component of the industry’s continued growth and safety, and what Job Snob has created will make finding qualified and safe providers much easier. When combined with AmSpa’s resources and growing membership, this alliance will allow the medical spa industry to provide high-quality and safe procedures to meet the growing public demand.”

“Partnering with AmSpa has been a goal for us since the beginning,” says Job Snob co-founder, Bree Black. “Now that everything is finally coming together, we couldn’t be more excited to offer our members even more exclusive career opportunities, as well as AmSpa’s industry-leading training and business resources.”

About Job Snob

Job Snob offers concierge recruiting services, an industry-specific job board, and practice acquisition services for medical aesthetic practices nationwide. Job Snob was founded by Kipper Doughty and Bree Black, who met during their time working with Allergan Aesthetics as business development managers in Beverly Hills, California. Job Snob’s team of recruiters works with practices nationwide, specializing in the placement of Aesthetic Injectors, Practice managers, medical directors, aestheticians, patient care coordinators and more.

About the American Med Spa Association (AmSpa)

The American Med Spa Association (AmSpa) provides business, legal and clinical training and resources to medical spas and aesthetic practices throughout the country. AmSpa’s events—including Medical Spa Boot Camps, Academy for Injection Anatomy trainings and Medical Spa Show—provide business and legal best-practices to anyone entering the medical spa space or looking to improve their existing practice. AmSpa Members receive access to legal summaries of laws governing medical spas in their state, discounts, a robust and growing webinar library, and many other benefits. For more information visit http://www.americanmedspa.org, call 312-981-0993, or email info@americanmedspa.org.

Share article on social media or email:

FYZICAL Therapy & Balance Centers Begins Its 10th Year of Franchising, Celebrating Momentous Achievement


FYZICAL Therapy & Balance Centers, the country’s fastest-growing physical therapy franchise with 500 open centers across 44 states, rounded out an outstanding year. As it celebrates a decade of franchising, FYZICAL also marks the opening of its 500th clinic in early 2023. The brand opened 86 new clinics and signed 90 new franchise deals in 2022, with unit-level revenues up 18% year-over-year, serving thousands more patients!

“After 10 years of franchising, we’ve certainly learned a lot along the way,” said Brian Belmont, CEO of FYZICAL. “As FYZICAL has grown, we have continued to reinvest in the business through technology and business intelligence that has allowed us to provide business support and revenue cycle management support to help scale the brand while continuously focusing on patient care and consumer wellness.”

This robust support is one of the critical factors in franchisees’ success with the brand. “Since joining FYZICAL over seven years ago, we have grown 700%,” explained Jerry Yarborough, owner of three FYZICAL locations in Ruston and Jonesboro, Louisiana, and El Dorado, Arkansas. “With all that’s in the works right now, we expect to double that next year. Being a part of FYZICAL has been a huge part of our success — the FYZICAL family is priceless.”

In early January, Franchise Business Review’s 2023 Top 50 Enterprise list ranked FYZICAL at number 21 across its 400+ unit classification, also securing a top placement in its category of Health and Personal Services. Franchise Business Review ranks franchisors based on franchisee satisfaction, evaluated by available training and support as well as a direct survey of franchisees. The concept’s high franchisee satisfaction scores directly result from FYZICAL’s franchisee support and proven, flexible business models.

As FYZICAL continues to grow, Belmont says there is more patient access than ever. FYZICAL provides a comprehensive, one-on-one approach to patient care, delivering personalized wellness and unmatched quality outcomes.

“What we’ve done is provide a service that’s never been offered to the market at scale,” he explained. “We’ve revolutionized it from a franchise perspective. We’re the only concept in outpatient physical therapy doing what we do.”

In 2021, the U.S. occupational and physical therapy market was valued at nearly $48 billion and is expected to reach $72.7 billion by 2029. FYZICAL offers traditional physical therapy services, specializing in orthopedics, sports medicine, neurological rehabilitation, manual therapy and pelvic health. The brand differentiates itself through FYZICAL’s Balance Paradigm and Sensory Mismatch programs. These proprietary offerings have helped revolutionize the treatment of balance patients. Falls are the leading cause of fatal and nonfatal injuries among older adults, and more than 10 million people suffer from dizziness each year. FYZICAL continues to help patients recover from injury and get back to doing what they love. The brand is an entry point for those looking to improve their health and wellness.

“We will continue to provide the best care in an integrated way in the U.S. and, eventually, internationally,” Belmont added. “We’ve accomplished a lot in the first 10 years of franchising, and we’re excited to see what the next 10 years will bring. Every day we strive for success for our owners, investors, and most importantly, successful outcomes for our patients.”

In 2023, the brand is projected to open another 100+ units as it continues to grow, seeking qualified franchisees to support its expansion in cities like Kansas City, Minneapolis, Indianapolis, Detroit, Philadelphia, and Boston. Individuals who are interested in capitalizing on an exploding industry and making a difference in the lives of others are positioned well for success.

To learn more about franchising with FYZICAL, visit fyzicalfranchise.com. To schedule an appointment at a clinic near you, visit fyzical.com.

About FYZICAL Therapy & Balance Centers

FYZICAL Therapy & Balance Centers is a physical therapy franchise with over 500 locations across 44 states. FYZICAL offers a medically based approach to health and wellness and offers comprehensive patient care through unique balance protocols and healthy lifestyle products and services. FYZICAL is a champion of patient choice and direct access, and a leader in the future of health, wellness and preventative care. For more information or to find the nearest location, please visit fyzical.com.

Share article on social media or email:

Local Manhattan Beach Dental Office Joins the Boys and Girls Clubs in the War Against Illiteracy!


Dr. Mungcal provides care with the goal of helping his patients keep their natural teeth for as long as possible, hopefully for life! This does not merely mean that natural teeth are present, but that they look good, feel good, and function well because of excellent care.

Dr. Mungcal, having served his community for many years, was quoted as saying, “This is an outrage! Only someone who doesn’t care about this city and our children would keep this quiet. Something should be done about this!”

During a special leadership event held in Florida, several business owners joined forces and decided to band together to do something about this.

They started by sending over 1,000 books to Boys and Girls Clubs in their communities. The mission of Boys and Girls Clubs is to enable all young people to reach their full potential as productive, caring, responsible citizens, especially those in need. These leaders support the vision of this national network of world-class clubs putting hope and safety within reach of every young person and putting them on track to graduate from high school with a plan for the future, learning good character and citizenship, and living a healthy lifestyle.

Reading is a cornerstone skill for our youth!

Dr. Mungcal said, “We want to do our part. And we want everyone in this city to know about this program and support it. Boys and Girls Clubs are leading the way in showing us that something can be done about it; something can be done about illiteracy by everyone pitching in.” and further stated “I believe that children and young adults who are shown what’s possible through literature can achieve their dreams. What’s more, receiving the gift of reading really makes them happy and ignites their imagination. I love making giving them this opportunity.”

About the Doctor

Dr. Don Mungcal:

Dr. Don Mungcal is a native of the Los Angeles area and loves serving his neighbor’s dental needs. Raised in the San Fernando Valley, he completed undergrad studies at UCLA. He received his degree with honors in 1990 after completing the dental program at University of the Pacific Dental School in San Francisco. His post-graduate experience came in part from his role as an instructor at USC Dental School. Within a few short years, Dr. Mungcal established his practice right in his hometown of Los Angeles. Manhattan Beach Dental has been serving patients since 1992.

He has been honored as a Best Dentist in Downtown in “Los Angeles Downtown News” for four consecutive years.

Dr. Mungcal stays abreast of cutting-edge dental technologies and techniques through activity in the California Dental Society. He is also a member of several other prestigious dental organizations. He stays up to date with the latest dental implants, general dentistry, and cosmetic dentistry advancements by investing hundreds of hours in continuing education courses each year.

Dr. Mungcal provides care with the goal of helping his patients keep their natural teeth for as long as possible, hopefully for life! This does not merely mean that natural teeth are present, but that they look good, feel good, and function well because of excellent care.

Dr. Don Mungcal

Beachside Smiles

Family & Cosmetic Dentistry

1590 Rosecrans Ave Ste. N

Manhattan Beach, CA 90266

310-643-6004

info@beachsidesmiles.com

Share article on social media or email:

Luminex to Host their 2023 Virtual xMAP Connect Conference, January 31, 2023


Luminex to Host their 2023 Virtual xMAP Connect Conference, January 31, 2023

Luminex to host their Virtual xMAP Connect Conference on January 31st, 2023 on the Labroots platform.

At Luminex’s Virtual Conference, expect to learn about their xMAP Technology, and how it enables to evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. Luminex’s xMAP Technology offers the versatility to perform a wide range or protein or nucleic acid based multiplex assays on a single platform.

During this virtual program, you can expect to hear from multiplex experts about how they’ve developed, validated, and optimized their methods, as well as learn about innovative research and clinical applications of xMAP Technology.

Join the xMAP Connect Virtual Event to

  • View webinars and posters—by scientists, for scientists—to gain insights from industry experts
  • Access a wide selection of resources, such as white papers, application notes, technical handbooks, product demo videos, and product selection guides
  • Join Luminex’s live Q&A session to connect with application scientists and speakers from the webinars to get multiplexing tips and tricks, plus troubleshooting help
  • Visit Luminex Partner booths to learn more about xMAP-based multiplexing solutions

To register for the event, and view the agenda, click here.

About Luminex

At Luminex, we envision a solution in every lab around the world seeking to obtain timely and confident answers. We aim to lead with transformative solutions that uniquely accelerate reliable answers while reducing the overall cost of advancing health. Luminex offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. They accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. For more information, visit Luminexcorp.com.

About Labroots

Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Now, Labroots offers more than ever with Chati, a flexibile highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Share article on social media or email:

Life Molecular Imaging Announces Start of the Phase 3 Histopathology Study “ADvance” for the Tau PET Tracer [18F]PI-2620


ADvance - [18F]PI-2620 Phase 3 histopathology study

ADvance – [18F]PI-2620 Phase 3 histopathology study

We are proud to announce the start of this Phase 3 study, which marks another milestone on our vision to reduce the burden of disease by improving early diagnosis and characterization of chronic and life-threatening diseases.

Life Molecular Imaging (LMI) announces today that the first patient has been imaged with [18F]PI-2620 in the ADvance Phase 3 clinical study. This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer’s disease (AD) during lifetime when compared to histopathology obtained after death and completion of brain autopsy.

The ADvance study will be performed exclusively in the US and will enroll approximately 200 end-of-life subjects. The primary objective is to determine the sensitivity and specificity of the visual assessment of [18F]PI-2620 PET imaging compared to postmortem histopathological verification of tau neurofibrillary pathology associated with AD as the standard of truth.

[18F]PI-2620 is a potentially best-in-class tau PET tracer with high binding affinity and selectivity for aggregated tau. Tau aggregates are an important indicator of neuronal death and correlate strongly with cognitive decline in AD. Accurate detection of aggregated tau may therefore contribute to improved diagnosis and advanced monitoring of cognitive performance in patients with dementia.

“A validated tau PET tracer will lead to an improved understanding of the pathophysiology of tauopathies and may aid in establishing an earlier and more accurate clinical diagnosis of neurodegenerative diseases”, said Dr. Ludger Dinkelborg, CEO of Life Molecular Imaging. “We are proud to announce the start of this Phase 3 study, which marks another milestone on our vision to reduce the burden of disease by improving early diagnosis and characterization of chronic and life-threatening diseases. This unique tau imaging biomarker is an important addition to Neuraceq®, our approved and globally available beta-amyloid targeting product, thereby complementing our neurodegeneration portfolio”.

Dr. Andrew Stephens, M.D., Ph.D., Chief Medical Officer at Life Molecular Imaging added: “We are highly encouraged by the clinical data obtained to date with our tau PET tracer [18F]PI-2620. We are very much looking forward to continuing the development of [18F]PI-2620 as the potentially best-in-class tau PET tracer in patients with AD by starting this Phase 3 study.”

The availability of a reliable and validated diagnostic agent to visualize disease development in patients with AD is critical for the successful development of novel therapies targeting amyloid and tau deposition. [18F]PI-2620 has the potential to become a diagnostic agent that can identify tau in AD and other tauopathies at an early stage and will help to advance the understanding of the pathophysiology of neurodegenerative diseases.

Further details of the ADvance Phase 3 study design are available on clinicaltrials.gov (NCT05641688).

About [18F]PI-2620

[18F]PI-2620 was discovered and developed as part of a research collaboration between AC Immune and LMI. LMI has the exclusive, worldwide license for research, development and commercialization of tau PET tracers generated within the discovery program. It has demonstrated robust brain uptake and fast wash-out in non-target regions, a broad imaging window between 30 and 90 minutes post-injection for AD, and excellent reproducibility between test and retest scans. The absence of significant off-target binding enables [18F]PI-2620 to detect and quantify early tau deposition in the brain.

[18F]PI-2620 is currently under investigation in several clinical studies as a targeted radiopharmaceutical for the detection of tau deposits in the human brain. [18F]PI-2620 also shows promise for non-AD tauopathies like progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).

About Neuraceq® (florbetaben 18F)

Indication

Neuraceq® is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate beta amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.

A negative Neuraceq® scan indicates sparse to no amyloid neuritic plaques and is inconsistent with a neuropathological diagnosis of AD at the time of image acquisition; a negative scan result reduces the likelihood that a patient’s cognitive impairment is due to AD. A positive Neuraceq® scan indicates moderate to frequent amyloid neuritic plaques; neuropathological examination has shown this amount of amyloid neuritic plaque is present in patients with AD but may also be present in patients with other types of neurologic conditions as well as older people with normal cognition. Neuraceq® is an adjunct to other diagnostic evaluations.

Limitations of Use

A positive Neuraceq® scan does not establish the diagnosis of AD or any other cognitive disorder.

Safety and effectiveness of Neuraceq® have not been established for (i) predicting development of dementia or other neurologic conditions and (ii) monitoring responses to therapies.

Important Safety Information

Risk for Image Interpretation and Other Errors

Neuraceq® can be used to estimate the density of beta-amyloid neuritic plaque deposition in the brain. Neuraceq® is an adjunct to other diagnostic evaluations. Neuraceq® images should be interpreted independent of a patient’s clinical information. Physicians should receive training prior to interpretation of Neuraceq® images. Following training, image reading errors (especially false positives) may still occur. Additional interpretation errors may occur due to, but not limited to, motion artifacts or extensive brain atrophy.

Radiation Risk

Administration of Neuraceq®, like other radiopharmaceuticals, contributes to a patient´s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. It is important to ensure safe handling to protect patients and health care workers from unintentional radiation exposure.

Most Common Adverse Reactions

In clinical trials, the most frequently observed adverse drug reactions in 872 subjects with 1090 Neuraceq® administrations were injection/application site erythema (1.7%), injection site irritation (1.1%), and injection site pain (3.4%).

For full prescribing information visit https://neuraceq.com/wp-content/uploads/2022/09/PRESCRIBING-INFORMATION.pdf

About Life Molecular Imaging (LMI)

Life Molecular Imaging (LMI, formerly Piramal Imaging) was formed in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG. It is now part of the Alliance Medical Group (a member of the Life Healthcare Group) offering an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. By developing novel PET tracers for molecular imaging, LMI is focusing on a key field of modern medicine. The organization strives to be a leader in the Molecular Imaging field by developing innovative products that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life. Please visit https://life-mi.com.

About Life Healthcare Group

Life Healthcare is a global people-centered, diversified healthcare organization listed on the Johannesburg Stock Exchange. Life Healthcare has over 38 years’ experience in the South African private healthcare sector, and currently operates 66 healthcare facilities in southern Africa. Services include acute hospital care, acute physical rehabilitation, acute mental healthcare, renal dialysis, and wellness, occupational health, primary health and emergency medical services. The Group owns Alliance Medical Group, the leading independent provider of medical imaging services (MRI, CT and PET scans) within Europe, operating internationally across 10 countries. Life Molecular Imaging, a division of Alliance is an integrated pharmaceutical business that includes research and development laboratories, access to a network of cyclotrons and radio-pharmacies and imaging facilities, with Life Radiopharma being Alliance’s distributor of radiopharmaceuticals to diagnose many types of diseases. Visit https://www.lifehealthcare.co.za/

For media inquiries

Contact:

Andre Mueller, Clinical & Preclinical R&D, Life Molecular Imaging, ADvance@life-mi.com

Share article on social media or email: